SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060226
Filing Date
2023-11-07
Accepted
2023-11-07 16:05:34
Documents
72
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bdsx-20230930.htm   iXBRL 10-Q 2791113
2 EX-31.1 bdsx-ex31_1.htm EX-31.1 16231
3 EX-31.2 bdsx-ex31_2.htm EX-31.2 16249
4 EX-32.1 bdsx-ex32_1.htm EX-32.1 8512
5 EX-32.2 bdsx-ex32_2.htm EX-32.2 8756
  Complete submission text file 0000950170-23-060226.txt   11235454

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bdsx-20230930.xsd EX-101.SCH 84481
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bdsx-20230930_def.xml EX-101.DEF 351413
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bdsx-20230930_lab.xml EX-101.LAB 699056
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bdsx-20230930_pre.xml EX-101.PRE 518543
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bdsx-20230930_cal.xml EX-101.CAL 56370
66 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-20230930_htm.xml XML 1995798
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

IRS No.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39659 | Film No.: 231383651
SIC: 8071 Services-Medical Laboratories